Meloxicam NDC 31722-227

NDC codes

FDA NDC Directory

Product NDC (as listed)31722-227Labeler and product segments. Claims need a package NDC.

Product NDC at billing width31722-0227Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
31722-227-01	31722022701	100 TABLET in 1 BOTTLE (31722-227-01)Marketed from Jun 8, 2023
31722-227-05	31722022705	500 TABLET in 1 BOTTLE (31722-227-05)Marketed from Jun 8, 2023
31722-227-31	31722022731	1000 TABLET in 1 BOTTLE (31722-227-31)Marketed from Jun 8, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Meloxicam
Generic name (nonproprietary): meloxicam
Active ingredients: Meloxicam — 15 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Camber Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217579
Marketing start: Jun 8, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 31722-227_a03cf994-d1b6-44fb-a2e8-ba67e8ee2b7cSPL ID a03cf994-d1b6-44fb-a2e8-ba67e8ee2b7cSPL set ID 5265e241-ab6a-400f-809f-5992f36c5593RxCUI 152695, 311486UNII VG2QF83CGL
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N431722022701 followed by a unit qualifier and the quantity

Package 31722-0227-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 16, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

1. INDICATIONS AND USAGE Meloxicam tablets are a non-steroidal anti-inflammatory drug indicated for: Osteoarthritis (OA) (1.1) Rheumatoid Arthritis (RA) (1.2) Juvenile Rheumatoid Arthritis (JRA) in patients who weigh ≥60 kg (1.3) 1.1 Osteoarthritis (OA) Meloxicam tablets are indicated for relief of the signs and symptoms of osteoarthritis [see Clinical Studies (14.1)]. 1.2 Rheumatoid Arthritis (RA) Meloxicam tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis [see Clinical Studies (14.1)]. 1.3 Juvenile Rheumatoid Arthritis (JRA) Pauciarticular and Polyarticular Course Meloxicam tablets are indicated for relief of the signs and symptoms of pauciarticular or poly…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 217579

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217579
Product	Strength	Form · route	Labeler	Product NDC
Meloxicam	Meloxicam 15 mg/1	TabletOral	XLCare Pharmaceuticals, Inc.	72865-333
Meloxicam	Meloxicam 7.5 mg/1	TabletOral	XLCare Pharmaceuticals, Inc.	72865-332
Meloxicam	Meloxicam 7.5 mg/1	TabletOral	Camber Pharmaceuticals, Inc.	31722-226